HONG KONG, and SHANGHAI, China and FLORHAM PARK, N.J., March 31, 2022 HUTCHMED Limited provides an update on its status under the Holding Foreign Companies Accountable Act , following the. | March 31, 2022
07.03.2022 - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 07, 2022 (GLOBE NEWSWIRE) - (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has received a US$15 million milestone payment from AstraZeneca PLC (“AstraZeneca”) .